Immunogen IMGN reported its Q2 earnings results on Friday, July 29, 2022 at 06:30 AM.
Here’s what investors need to know about the announcement.
Immunogen missed estimated earnings by 14.29%, reporting an EPS of $-0.24 versus an estimate of $-0.21.
Revenue was down $2.79 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.11 which was followed by a 4.54% drop in the share price the next day.
Here’s a look at Immunogen’s past performance:
|Quarter||Q1 2022||Q4 2021||Q3 2021||Q2 2021|
To track all earnings releases for Immunogen visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
Image and article originally from www.benzinga.com. Read the original article here.